These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 25043977)
1. Identification of important residues of insulin-like peptide 5 and its receptor RXFP4 for ligand-receptor interactions. Wang XY; Guo YQ; Shao XX; Liu YL; Xu ZG; Guo ZY Arch Biochem Biophys; 2014 Sep; 558():127-32. PubMed ID: 25043977 [TBL] [Abstract][Full Text] [Related]
2. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation. Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387 [TBL] [Abstract][Full Text] [Related]
3. Interaction mechanism of insulin-like peptide 5 with relaxin family peptide receptor 4. Hu MJ; Wei D; Shao XX; Wang JH; Liu YL; Xu ZG; Guo ZY Arch Biochem Biophys; 2017 Apr; 619():27-34. PubMed ID: 28274616 [TBL] [Abstract][Full Text] [Related]
4. The C-terminus of the B-chain of human insulin-like peptide 5 is critical for cognate RXFP4 receptor activity. Patil NA; Bathgate RAD; Kocan M; Ang SY; Tailhades J; Separovic F; Summers R; Grosse J; Hughes RA; Wade JD; Hossain MA Amino Acids; 2016 Apr; 48(4):987-992. PubMed ID: 26661035 [TBL] [Abstract][Full Text] [Related]
5. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135). Zhu J; Kuei C; Sutton S; Kamme F; Yu J; Bonaventure P; Atack J; Lovenberg TW; Liu C Eur J Pharmacol; 2008 Aug; 590(1-3):43-52. PubMed ID: 18582868 [TBL] [Abstract][Full Text] [Related]
6. Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework. Haugaard-Jönsson LM; Hossain MA; Daly NL; Craik DJ; Wade JD; Rosengren KJ Biochem J; 2009 May; 419(3):619-27. PubMed ID: 19178384 [TBL] [Abstract][Full Text] [Related]
7. Structure and function relationship of murine insulin-like peptide 5 (INSL5): free C-terminus is essential for RXFP4 receptor binding and activation. Belgi A; Hossain MA; Shabanpoor F; Chan L; Zhang S; Bathgate RA; Tregear GW; Wade JD Biochemistry; 2011 Oct; 50(39):8352-61. PubMed ID: 21866895 [TBL] [Abstract][Full Text] [Related]
8. Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4. Hu MJ; Shao XX; Wang JH; Wei D; Guo YQ; Liu YL; Xu ZG; Guo ZY Sci Rep; 2016 Jul; 6():29648. PubMed ID: 27404393 [TBL] [Abstract][Full Text] [Related]
9. Relaxin-3, INSL5, and their receptors. Liu C; Lovenberg TW Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022 [TBL] [Abstract][Full Text] [Related]
10. A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays. Zhang WJ; Jiang Q; Wang XY; Song G; Shao XX; Guo ZY J Pept Sci; 2013 Jun; 19(6):350-4. PubMed ID: 23526726 [TBL] [Abstract][Full Text] [Related]
11. Exploring electrostatic interactions of relaxin family peptide receptor 3 and 4 with ligands using a NanoBiT-based binding assay. Wang JH; Nie WH; Shao XX; Li HZ; Hu MJ; Liu YL; Xu ZG; Guo ZY Biochim Biophys Acta Biomembr; 2019 Apr; 1861(4):776-786. PubMed ID: 30684458 [TBL] [Abstract][Full Text] [Related]
12. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor. Ang SY; Hutchinson DS; Patil N; Evans BA; Bathgate RAD; Halls ML; Hossain MA; Summers RJ; Kocan M Br J Pharmacol; 2017 May; 174(10):1077-1089. PubMed ID: 27243554 [TBL] [Abstract][Full Text] [Related]
13. The actions of relaxin family peptides on signal transduction pathways activated by the relaxin family peptide receptor RXFP4. Ang SY; Hutchinson DS; Evans BA; Hossain MA; Patil N; Bathgate RA; Kocan M; Summers RJ Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):105-111. PubMed ID: 27888281 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, conformation, and activity of human insulin-like peptide 5 (INSL5). Akhter Hossain M; Bathgate RA; Kong CK; Shabanpoor F; Zhang S; Haugaard-Jönsson LM; Rosengren KJ; Tregear GW; Wade JD Chembiochem; 2008 Jul; 9(11):1816-22. PubMed ID: 18576448 [TBL] [Abstract][Full Text] [Related]
15. Relaxin family peptides and their receptors. Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914 [TBL] [Abstract][Full Text] [Related]
16. Engineering of chimeric peptides as antagonists for the G protein-coupled receptor, RXFP4. Praveen P; Bathgate RAD; Hossain MA Sci Rep; 2019 Nov; 9(1):17828. PubMed ID: 31780677 [TBL] [Abstract][Full Text] [Related]
17. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays. Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442 [TBL] [Abstract][Full Text] [Related]
18. Design and recombinant expression of insulin-like peptide 5 precursors and the preparation of mature human INSL5. Luo X; Bathgate RA; Zhang WJ; Liu YL; Shao XX; Wade JD; Guo ZY Amino Acids; 2010 Nov; 39(5):1343-52. PubMed ID: 20383778 [TBL] [Abstract][Full Text] [Related]
19. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways. Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890 [TBL] [Abstract][Full Text] [Related]
20. Expression and localization of relaxin family peptide receptor 4 in human spermatozoa and impact of insulin-like peptide 5 on sperm functions. Yeganeh IS; Taromchi AH; Fathabadi FF; Nejatbakhsh R; Novin MG; Shokri S Reprod Biol; 2017 Dec; 17(4):327-332. PubMed ID: 28986276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]